Vanda Pharmaceuticals: IOMachine Says This Is A Buy [Seeking Alpha]
Vanda Pharmaceuticals Inc. (VNDA)
Last vanda pharmaceuticals inc. earnings: 2/25 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=196233&p=irol-irhome
Company Research
Source: Seeking Alpha
Announcement : ACP will run a one day discount campaign on December 26, Boxing Day. On that day, you can get the Annual TPT membership at 30% discount, for just $350. More details here . ..... Vanda Pharmaceuticals ( VNDA ) has a current revenue stream, a strong cash balance, and a long-tailed pipeline from where we saw recent positive data in a mid-stage trial. The stock is down 25% from its recently achieved 52-week high, presenting an investing opportunity for the long-term investor. In the last one month, Vanda announced data from two of its product candidates, HETLIOZ (an existing product) in Smith-Magenis Syndrome (SMS) and tradipitant in patients with idiopathic and diabetic gastroparesis. The company has an existing pipeline consisting of HETLIOZ and Fanapt, whose financial figures are as follows: • HETLIOZ net product sales for 2017 are expected to be approximately $90 million, consistent with Vanda's prior guidance of between $89 million and $9
Show less
Read more
Impact Snapshot
Event Time:
VNDA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VNDA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VNDA alerts
High impacting Vanda Pharmaceuticals Inc. news events
Weekly update
A roundup of the hottest topics
VNDA
News
- Vanda Pharmaceuticals (VNDA) Stock Sinks As Market Gains: What You Should Know [Yahoo! Finance]Yahoo! Finance
- Vanda (VNDA) to Report Q1 Earnings: What's in the Cards? [Yahoo! Finance]Yahoo! Finance
- Vanda Pharmaceuticals Reacts to U.S. Supreme Court's Denial of its Petition in HETLIOZ® ANDA Litigation [Yahoo! Finance]Yahoo! Finance
- Vanda Pharmaceuticals Reacts to U.S. Supreme Court's Denial of its Petition in HETLIOZ® ANDA LitigationPR Newswire
- Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
VNDA
Earnings
- 2/7/24 - Beat
VNDA
Analyst Actions
- 2/9/24 - TheStreet
VNDA
Sec Filings
- 4/17/24 - Form 8-A12B
- 4/17/24 - Form 8-K
- 4/3/24 - Form 8-K
- VNDA's page on the SEC website